Regulation of matrilysin expression in endothelium by fibroblast growth factor-2

Biochemical and Biophysical Research Communications

Volumn 342, Issue 3, 2006, Pages 725-733

  Holnthoner, Wolfgang ^a   Kerenyi, Marc ^b   Gröger, Marion ^a   Kratochvill, Franz ^a   Petzelbauer, Peter ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

AP 1; Endothelium; FGF 2; Lef Tcf; Matrilysin; MMP7; Stat1; Stat3

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; LYMPHOID ENHANCER FACTOR 1; MATRILYSIN; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT2 PROTEIN; T CELL FACTOR PROTEIN;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; WILD TYPE;

BINDING SITES; CULTURE MEDIA, SERUM-FREE; ENDOTHELIAL CELLS; ENDOTHELIUM; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MATRIX METALLOPROTEINASE 7; MODELS, GENETIC; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RNA, MESSENGER; RNA, SMALL INTERFERING; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-1;

EID: 33644618969     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.011     Document Type: Article

References (34)

1. W. Risau Mechanisms of angiogenesis Nature 386 1997 671 674
2. S.J. Monkley, S.J. Delaney, D.J. Pennisi, J.H. Christiansen, and B.J. Wainwright Targeted disruption of the Wnt2 gene results in placentation defects Development 122 1996 3343 3353
3. Q. Xu, Y. Wang, A. Dabdoub, P.M. Smallwood, J. Williams, C. Woods, M.W. Kelley, L. Jiang, W. Tasman, K. Zhang, and J. Nathans Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair Cell 116 2004 883 895
4. K. Venkiteswaran, K. Xiao, S. Summers, C.C. Calkins, P.A. Vincent, K. Pumiglia, and A.P. Kowalczyk Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and beta-catenin Am. J. Physiol. Cell Physiol. 283 2002 C811 C821
5. T. Halama, M. Groger, M. Pillinger, G. Staffler, E. Prager, H. Stockinger, W. Holnthoner, S. Lechleitner, K. Wolff, and P. Petzelbauer Platelet endothelial cell adhesion molecule-1 and vascular endothelial cadherin cooperatively regulate fibroblast growth factor-induced modulations of adherens junction functions J. Invest. Dermatol. 116 2001 110 117
6. W. Holnthoner, M. Pillinger, M. Groger, K. Wolff, A.W. Ashton, C. Albanese, P. Neumeister, R.G. Pestell, and P. Petzelbauer Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells J. Biol. Chem. 277 2002 45847 45853
7. Z. Ai, A. Fischer, D.C. Spray, A.M. Brown, and G.I. Fishman Wnt-1 regulation of connexin43 in cardiac myocytes J. Clin. Invest. 105 2000 161 171
8. M. Shtutman, J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, and A. Ben Ze'ev The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway Proc. Natl. Acad. Sci. USA 96 1999 5522 5527
9. D. Gradl, M. Kuhl, and D. Wedlich The Wnt/Wg signal transducer beta-catenin controls fibronectin expression Mol. Cell Biol. 19 1999 5576 5587
10. V. Easwaran, S.H. Lee, L. Inge, L. Guo, C. Goldbeck, E. Garrett, M. Wiesmann, P.D. Garcia, J.H. Fuller, V. Chan, F. Randazzo, R. Gundel, R.S. Warren, J. Escobedo, S.L. Aukerman, R.N. Taylor, and W.J. Fantl Beta-Catenin regulates vascular endothelial growth factor expression in colon cancer Cancer Res. 63 2003 3145 3153
11. B. Mann, M. Gelos, A. Siedow, M.L. Hanski, A. Gratchev, M. Ilyas, W.F. Bodmer, M.P. Moyer, E.O. Riecken, H.J. Buhr, and C. Hanski Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas Proc. Natl. Acad. Sci. USA 96 1999 1603 1608
12. G.N. Marchenko, N.D. Marchenko, J. Leng, and A.Y. Strongin Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin Biochem. J. 363 2002 253 262
13. Y. Nagashima, S. Hasegawa, N. Koshikawa, A. Taki, Y. Ichikawa, H. Kitamura, K. Misugi, Y. Kihira, Y. Matuo, H. Yasumitsu, and K. Miyazaki Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors Int. J. Cancer 72 1997 441 445
14. S. Hasegawa, N. Koshikawa, N. Momiyama, K. Moriyama, Y. Ichikawa, T. Ishikawa, M. Mitsuhashi, H. Shimada, and K. Miyazaki Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model Int. J. Cancer 76 1998 812 816
15. N. Momiyama, N. Koshikawa, T. Ishikawa, Y. Ichikawa, S. Hasegawa, Y. Nagashima, M. Mitsuhashi, K. Miyazaki, and H. Shimada Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro Mol. Carcinog. 22 1998 57 63
16. T. Brabletz, A. Jung, S. Dag, F. Hlubek, and T. Kirchner Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer Am. J. Pathol. 155 1999 1033 1038
17. H.C. Crawford, B. Fingleton, M.D. Gustavson, N. Kurpios, R.A. Wagenaar, J.A. Hassell, and L.M. Matrisian The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors Mol. Cell Biol. 21 2001 1370 1383
18. P. Petzelbauer, J.R. Bender, J. Wilson, and J.S. Pober Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture J. Immunol. 151 1993 5062 5072
19. C. Rivat, N. Le Floch, M. Sabbah, I. Teyrol, G. Redeuilh, E. Bruyneel, M. Mareel, L.M. Matrisian, H.C. Crawford, C. Gespach, and S. Attoub Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion FASEB J. 17 2003 1721 1723
20. I.H. Oh, and C.J. Eaves Overexpression of a dominant negative form of STAT3 selectively impairs hematopoietic stem cell activity Oncogene 21 2002 4778 4787
21. P.J. Morin, A.B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, and K.W. Kinzler Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC Science 275 1997 1787 1790
22. H.C. Crawford, B.M. Fingleton, L.A. Rudolph-Owen, K.J. Goss, B. Rubinfeld, P. Polakis, and L.M. Matrisian The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors Oncogene 18 1999 2883 2891
23. M.S. Stratton, H. Sirvent, T.S. Udayakumar, R.B. Nagle, and G.T. Bowden Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines Prostate 48 2001 206 209
24. T.S. Udayakumar, M.S. Stratton, R.B. Nagle, and G.T. Bowden Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3 Neoplasia 4 2002 60 67
25. D.D. Deo, T.W. Axelrad, E.G. Robert, V. Marcheselli, N.G. Bazan, and J.D. Hunt Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism J. Biol. Chem. 277 2002 21237 21245
26. G.B. Ehret, P. Reichenbach, U. Schindler, C.M. Horvath, S. Fritz, M. Nabholz, and P. Bucher DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites J. Biol. Chem. 276 2001 6675 6688
27. H.M. Seidel, L.H. Milocco, P. Lamb, J.E. Darnell Jr., R.B. Stein, and J. Rosen Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity Proc. Natl. Acad. Sci. USA 92 1995 3041 3045
28. E. Caldenhoven, T.B. van Dijk, R. Solari, J. Armstrong, J.A. Raaijmakers, J.W. Lammers, L. Koenderman, and R.P. de Groot STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription J. Biol. Chem. 271 1996 13221 13227
29. Z. Dong, R.H. Xu, J. Kim, S.N. Zhan, W.Y. Ma, N.H. Colburn, and H. Kung AP-1/jun is required for early Xenopus development and mediates mesoderm induction by fibroblast growth factor but not by activin J. Biol. Chem. 271 1996 9942 9946
30. U. Bavendiek, P. Libby, M. Kilbride, R. Reynolds, N. Mackman, and U. Schonbeck Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1 J. Biol. Chem. 277 2002 25032 25039
31. M. Sahni, D.C. Ambrosetti, A. Mansukhani, R. Gertner, D. Levy, and C. Basilico FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway Genes Dev. 13 1999 1361 1366
32. C.L. Wilson, and L.M. Matrisian Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions Int. J. Biochem. Cell Biol. 28 1996 123 136
33. C.C. Lynch, H.C. Crawford, L.M. Matrisian, and S. McDonnell Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors Int. J. Oncol. 24 2004 1565 1572
34. Q. Eastman, and R. Grosschedl Regulation of LEF-1/TCF transcription factors by Wnt and other signals Curr. Opin. Cell Biol. 11 1999 233 240